| Date | Title | Description |
| 11.09.2024 | Versatope Launches Clinical Development Team for VT-105, a Pan-influenza A Vaccine Candidate | LOWELL, Mass., Sept. 11, 2024 /PRNewswire/ -- Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today their new Chief Medical Officer, Dr. M.P. Anza Mammen, MD and the additio... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 29.04.2024 | Chromosome polymorphism a key factor in recurrent pregnancy loss: Study | - |
| 12.03.2024 | Proteomics Market is growing at a CAGR of 15.15% from 2024 to 2030 by Exactitude Consultancy | proteomics market
The Exactitude Consultancy Proteomics Market Report – Size, Trends, and Forecast 2024-2030
The proteomics market is experiencing high demand due to advancements in research, personalized medicine, and drug development.”
— ... |
| 11.03.2024 | Newborn Screening Market is growing at a CAGR of 8.89% from 2024 to 2030 by Exactitude Consultancy | Newborn Screening market
The Exactitude Consultancy Newborn Screening Market Report – Size, Trends, and Forecast 2024-2030
The Newborn Screening market is driven by rising awareness, technological advancements, and increasing government ini... |
| 05.12.2023 | PerkinElmer Acquires Covaris | PerkinElmer, Shelton, CT-based analytical services and solutions provider, acquired Covaris, a Woburn, MA-based developer of solutions to empower life science innovations.
The amount of the deal was not disclosed.
The merger will accelerate... |
| 03.02.2022 | PerkinElmer : to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Automated Genomic Workflows at SLAS 2022 | PDF Version
End-to-end solutions designed to help scientists streamline and improve
drug discovery R&D productivity
WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 ... |
| 11.01.2022 | PerkinElmer : 2022 JPM Healthcare Conference Presentation | J.P. MORGAN
Healthcare Conference
Prahlad Singh
Chief Executive Officer
January 11, 2022
1
SAFE HARBOR
This presentation contains "forward-looking" statements which are statements relating to future events. These statements includ... |
| 01.08.2021 | BioLegend to Be Acquired for $5.25 Billion | Photo Courtesy of BioLegend BioLegend’s San Diego facility will become PerkinElmer’s global Center of Excellence (CoE) for research reagent content development for the combined company. BioLegend, a global developer and manufacturer of anti... |
| 26.07.2021 | PerkinElmer : BioLegend Acquisition Infographic | PERKINELMER TO COMBINE WITH
BIOLEGEND, ACCELERATING
LEGENDARY DISCOVERIES
Transaction Features
Purchase price of $5.25B; $2.2B stock consideration with remainder from new debt and cash on hand, committed to remain investment grade
Enhanced ... |
| 26.07.2021 | PerkinElmer : to Acquire BioLegend | Unlocking Legendary Discovery
PerkinElmer to Combine with BioLegend
July 26, 2021
© 2021 PerkinElmer
SAFE HARBOR
This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Refor... |
| 26.07.2021 | PerkinElmer Agrees to Acquire BioLegend | PerkinElmer, Inc. (NYSE: PKI) entered into an agreement to acquire San Diego-based BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion. The acquisition deal will be a combination of... |
| 22.07.2021 | PerkinElmer : COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type | PDF Version
Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer
WHAT:PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the ... |
| 30.03.2021 | Horizon Discovery extends gene modulation portfolio | Horizon Discovery extends gene modulation portfolio
30-03-2021
CRISPRi innovations provide expanded experimental options and flexibility for researchers, facilitating disease and drug research.
Horizon Discovery, a PerkinElmer, Inc. (NYSE:P... |
| 30.03.2021 | Horizon Discovery extends gene modulation portfolio | CRISPRi innovations provide expanded experimental options and flexibility for researchers, facilitating disease and drug research.
Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, announced that its gene editing and modulation por... |
| 18.03.2021 | PerkinElmer Launches Industry-First CRM Reagent and Consumable Kit to Streamline Cannabis Pesticide Testing Workflows | WALTHAM, Mass.--(BUSINESS WIRE)--Mar 18, 2021--
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its ONE Pesticide 420 ™ CRM Reagent and Consumable Kit for cannabis & hemp testing. Initial... |
| 08.03.2021 | PerkinElmer Adds HPLC Columns to Consumables Portfolio | WALTHAM, Mass.--(BUSINESS WIRE)--Mar 8, 2021--
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added state-of-the-art columns and chemistries to its LC consumables portfolio by a... |
| 14.12.2020 | PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization | Carterra LSA Instrument We are thrilled to have PerkinElmer as an investor and look forward to working together to advance our shared visions to improve drug discovery and life science research.
SALT LAKE CITY (PRWEB) December 14, 2020
Cart... |
| 14.12.2020 | PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization | Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Current Carterra investors Telegraph Hill ... |
| 02.11.2020 | PerkinElmer buys out British gene editing player for $383M, boosting its diagnostics and genomic capabilites | PerkinElmer, the Massachusetts-based diagnostics and life sciences company, has a new acquisition, and it comes with a nearly $400 million price tag.
The company announced Monday that it has purchased UK gene editing bio... |
| 02.11.2020 | PerkinElmer to acquire cell engineering company Horizon Discovery for £296m ($383m) | PerkinElmer to acquire cell engineering company Horizon Discovery for £296m ($383m)
02-11-2020
PerkinElmer, Inc. and Cambridge based Horizon Discovery Group plc are pleased to announce that they have reached an agreement on the terms of a r... |
| 11.09.2019 | PerkinElmer prices $850m offering | PerkinElmer (NYSE:PKI) yesterday priced a stock offering of $850 million.
The offering consists of 3.3% senior notes due in 2029 at an issue price of 99.67% of the principal amount. PerkinElmer said it expects to complete the offering on Se... |
| 21.03.2018 | Lunaphore announces collaboration with American company | Congratulations on this new partnership! Where did you meet your new partner and what let you to form this collaboration?
Initially, Lunaphore wanted to buy a product from PerkinElmer. Exchanging with them, both parties saw a fit for a pote... |
| 21.03.2018 | Lunaphore announces collaboration with an American company | Lunaphore announces collaboration with an American company 21.03.2018 11:25, Charlotte Pichon linkedIn facebook twitter instagram youtube -->
Lunaphore Technologies SA, a Venturelab alumnus developing automation systems for tissue diagno... |
| 09.03.2016 | Attivio raises $31 million to help companies make sense of big data | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Attivio, a Newton, Massachusetts-based startup th... |
| 09.03.2016 | Attivio raises $31 million to help companies make sense of big data | Attivio, a Newton, Massachusetts-based startup that promises to “accelerate data discovery,” announced today that it closed a $31 million financing round.
The investment, the startup said, will help the company to meet investors’ expectatio... |
| 11.02.2016 | Attivio Expands Collaboration with PerkinElmer in the Life Sciences Industry | Attivio Expands Collaboration with PerkinElmer in the Life Sciences Industry
Attivio has expanded its strategic relationship with PerkinElmer, making PerkinElmer the exclusive reseller of Attivio solutions in the life sciences markets world... |
| 05.08.2015 | InSphero Expands Global Availability of its 3D Cell Culture Platforms | |
| 03.03.2015 | Johnson & Johnson opening another JLABS accelerator in South San Francisco | “That allows them to be free and really build value,” she said. The initial San Francisco spot, a 24-000 square-foot facility in the Dogpatch neighborhood, is at capacity and Johnson & Johnson needed a larger presence in the Bay Area in... |
| 24.11.2014 | New exit: Valedo divests Perten Instruments to PerkinElmer Inc. | Perten, founded in 1962, develops and markets instruments, along with a market leading food quality calibration database and ancillary services, for advanced quality control of food, grain, flour and feed. Over the last few years, Perten ha... |
| 15.06.2011 | Report: Consolidation ahead for medical device sector | Acquisitions Roundup | Impending federal excise taxes, downward pricing pressure and declining volumes of big-ticket procedures constitute a triple threat that will drive the medical device industry to consolidate, according to a PricewaterhouseCoopers report.
Th... |
| 01.12.2010 | PerkinElmer closes $500 million divestiture of IDS unit | PerkinElmer Inc. (NYSE:PKI) completed the offloading of its illumination and detection solutions business to a private equity firm for a half billion.
The unit went to Excelitas Technologies Corp., an affiliate of New York-based private equ... |
| 21.11.2010 | Personnel moves: Angeion announces CEO succession | Angeion announces CEO succession
Angeion Corp. (NSDQ:ANGN) today announced that Rodney Young, CEO of Angeion since 2004, is stepping down as CEO, but will continue as an Angeion director and a consultant to the company. The company also ann... |
| 31.08.2010 | PerkinElmer to deal IDS unit for $500 million | PerkinElmer Inc. (NYSE:PKI) plans to deal its illumination and detection solutions business to a private equity firm for a cool half billion.
The Waltham, Mass.-based diagnostics and equipment giant said it agreed to sell the IDS unit to Ve... |
| 10.08.2010 | PerkinElmer’s Q2 sales rise, earnings surge 168 percent | PerkinElmer Inc. (NYSE:PKI) posted strong second-quarter results as its efforts to boost its profile and expand its geographic footprint bore fruit.
The Waltham, Mass.-based diagnostics giant reported revenues of $497.8 million for the thre... |
| 26.05.2010 | Ohio Third Frontier approves biomedical project, investing grants | The five commissioners who attended Wednesday’s meeting voted unanimously to fund seven Wright Project grant proposals, including:
Cleveland Clinic: $3 million for its Clinically Applied Rehabilitation Engineering project, which aims at dev... |
| 07.05.2010 | PerkinElmer’s Q1 profits surge 130 percent | Supported in part by the positive effects of foreign currency conversions and several recent acquisitions, PerkinElmer Inc. (NYSE:PKI) generated a $24.4 million net profit, or 21 cents per share, on $465.1 million in revenues during the thr... |
| 05.02.2010 | PerkinElmer tops forecasts with 43-cent adjusted Q4 profit | Topping both analyst’s and its own prior estimates, adjusted fourth-quarter earnings at PerkinElmer Inc. (NYSE:PKI) rose handily despite a slight dip in revenues for the diagnostic and laboratory equipment maker.
Company executives said the... |
| 29.01.2010 | PerkinElmer CAO Walsh to retire | The administration chief for PerkinElmer Inc. (NYSE:PKI), Richard Walsh, plans to step down in March, according to a filing with the federal Securities and Exchange Commission.*
Walsh, who joined the Waltham, Mass.-based research and diagno... |
| - | Ohio Third Frontier approves biomedical project, investing grants | The Ohio Third Frontier Commission on Wednesday approved $20 million in Wright Project grants, including more than $8 million for three biomedical projects.
During their first meeting since voters approved an extension and expansion of the ... |
| - | EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics | WALTHAM, Mass.--(BUSINESS WIRE)--Mar 16, 2021--
EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern TM Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of t... |
| - | Johnson & Johnson opening another JLABS accelerator in South San Francisco | Life sciences giant Johnson & Johnson Innovation announced the opening of a fourth JLABS accelerator in South San Francisco that will accommodate up to 50 startups that span the healthcare landscape.
It’s the fourth JLABS to open, follo... |
| - | Successful Exit for Creathor Ventures, High-Tech Gründerfonds, Bayern Kapital and KfW – PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech | June 23, 2021 |
| - | Successful Exit for Creathor Ventures, High-Tech Gründerfonds, Bayern Kapital and KfW– PerkinElmer agrees to acquire Viral Vector Gene Delivery Leader SIRION Biotech | Bonn, June 23rd, 2021 – Creathor Ventures, High-Tech Gründerfonds, KfW and Bayern Kapital announced that they are committed to sell their shares of SIRION Biotech GmbH, a global provider of viral vector-based technologies that drive improve... |
